Hematologie nieuws
- AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B
- Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies
- High CD34?positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft?versus?host disease or mortality
- Survival of transfused red blood cells from a donor with alpha?thalassemia trait in a recipient with sickle cell disease
- Measuring the effectiveness of online search ads on blood donor recruitment and donation
- Downregulation of protein S in patients with severe COVID-19 augments the prothrombotic state
- Patterns of red blood cell utilization: Harnessing electronic health records data from the Information Standard for Blood and Transplant (ISBT) 128 system within the Biologics Effectiveness and Safety (BEST) initiative
- Labcorp gets US FDA approval for first companion diagnostic for use with Pfizer's newly approved gene therapy to treat patients with haemophilia B
- Sepsis-trained macrophages promote antitumoral tissue-resident T cells
- Pfizer’s Beqvez approved by FDA for haemophilia B treatment
- A thromboembolic event as the first presentation of essential thrombocytosis: A case report
- The course of pulmonary embolism in individuals recovered from COVID-19
- Effect of Apheresis Plasma Donation on Plasma Uric Acid Levels, the Lipid Profile, and Major Plasma Proteins in Plasma Donors in China: A Multicenter, Prospective Cohort Study
- The common variable immunodeficiency IgM repertoire narrowly recognizes erythrocyte and platelet glycans
- Pfizer's Beqvez receives US FDA approval for adults with moderate to severe haemophilia B who currently use FIX prophylaxis therapy